Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperpolarized Xenon-129 MRI in E-cigarette Users
NCT06856525Phase 3Recruiting
- Start
- Dec 2024
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 3, open-label trial (2 arms). Primary endpoints: Comparison of gas exchange between e-cig users and healthy participants at 12 months and Acute effects of e-cig in e-cig users before and after using one usual dose at 12 months. Started Dec 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06856525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06856525.